Earnings History Data for Incyte Corporation (INCY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Incyte Corporation

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
01-11-2022 PM 7:00 AM ET
(Nov 1)
INCY Incyte Corporation 16,590 0.44 0.54 1.00 Incyte Non-GAAP EPS of $0.60 misses by $0.10, revenue of $823.03M misses by $20.62M
[11/1/2022 7:03 AM]
76.99 2.65 
(3.56%)
75.02 0.68 
(0.91%)
61.91 - 84.86 3,658,542 1,720,000 10,342
02-08-2022 PM 7:00 AM ET
(Aug 2)
INCY Incyte Corporation 17,920 0.85 0.61 0.65 Incyte Non-GAAP EPS of $1.01 beats by $0.27, revenue of $911.4M beats by $93.15M
[8/2/2022 7:02 AM]
72.51 -4.89 
(-6.32%)
75.15 -2.25 
(-2.91%)
61.91 - 84.86 2,699,478 1,330,000 16,021
03-05-2022 PM 7:00 AM ET
(May 3)
INCY Incyte 16,688 0.40 0.57 0.00 Incyte Non-GAAP EPS of $0.55 misses by $0.14, revenue of $733.24M misses by $20.3M; reaffirms FY22 guidance
[5/3/2022 7:12 AM]
77.24 1.18 
(1.56%)
76.00 -0.05 
(-0.07%)
61.91 - 88.26 1,660,171 1,594,833 241
08-02-2022 PM 7:00 AM ET
(Feb 8)
INCY Incyte Corporation 16,140 -0.07 0.65 0.73 IncyteEPS of $0.10, revenue of $862.5M beats by $49.12M
[2/8/2022 7:02 AM]
70.06 -3.29 
(-4.49%)
71.00 -2.35 
(-3.20%)
61.91 - 94.50 2,812,729 1,790,000 30,077
02-11-2021 PM 7:00 AM ET
(Nov 2)
INCY Incyte Corporation 14,520 1.00 0.52 0.03 Incyte EPS beats by $0.43, beats on revenue
[11/2/2021 7:11 AM]
63.48 -5.87 
(-8.46%)
63.48 0.0 
(0.00%)
61.91 - 101.47 4,984,541 1,520,000 9,462
03-08-2021 PM 7:00 AM ET
(Aug 3)
INCY Incyte Corporation 17,010 0.65 0.54 1.04 Incyte EPS beats by $0.06, beats on revenue
[8/3/2021 7:07 AM]
77.96 -0.51 
(-0.65%)
77.70 -0.77 
(-0.98%)
75.52 - 102.61 1,360,307 1,310,000 2,351
04-05-2021 PM 7:00 AM ET
(May 4)
INCY Incyte Corporation 18,670 0.50 0.42 -3.05 Incyte EPS beats by $0.03, misses on revenue; reaffirms guidance
[5/4/2021 7:03 AM]
81.03 -4.49 
(-5.25%)
81.03 0.0 
(0.00%)
75.52 - 110.36 2,373,938 880,000 14,418
09-02-2021 PM 7:00 AM ET
(Feb 9)
INCY Incyte Corporation 19,760 0.73 0.64 0.50 Incyte EPS beats by $0.16, beats on revenue
[2/9/2021 7:01 AM]
89.51 -4.11 
(-4.39%)
94.50 0.88 
(0.94%)
62.48 - 110.36 1,184,102 1,097,613 8,168
05-11-2020 PM 7:00 AM ET
(Nov 5)
INCY Incyte Corporation 18,580 0.03 0.47 0.62 Incyte EPS misses by $0.53, misses on revenue
[11/5/2020 7:05 AM]
84.65 -6.56 
(-7.19%)
84.65 0.0 
(0.00%)
62.48 - 110.36 1,930,638 986,819 18,618
04-08-2020 PM 7:00 AM ET
(Aug 4)
INCY Incyte Corporation 21,470 1.04 0.68 0.56 Incyte EPS beats by $0.37, beats on revenue
[8/4/2020 7:02 AM]
98.45 -3.34 
(-3.28%)
102.49 0.70 
(0.69%)
62.48 - 110.36 943,186 1,113,492 10,963
05-05-2020 PM 7:00 AM ET
(May 5)
INCY Incyte Corporation 21,110 -3.05 0.31 0.47 Incyte EPS misses by $2.50, beats on revenue
[5/5/2020 7:06 AM]
99.31 -1.68 
(-1.66%)
99.58 -1.41 
(-1.40%)
62.48 - 104.81 549,209 1,718,626 6,482